The Red Dragon Conference is a voluntary study group for Asian development strategies and regulatory intelligence in the pharmaceutical industry cofounded by Mr. Tetsuomi Takano in October 2008, who was appointed as the Vice-Chairperson initially and has been promoted to the Chairperson since 2014.

On December 1st, 2023, we held the 29th Red Dragon Conference in Iidabashi, Tokyo in collaboration with EPS, where Mr. Tetsuomi Takano, the Chairperson of the Red Dragon Conference, gave a presentation titled “Update on Clinical Development and Regulatory for China” covering the following three contents.

Contents
1.  CDE Annual Reports 2022 (Sep. 6-7, 2023)
2.  China NMPA Townhall at 20th DIA Japan Annual Meeting (Nov. 6, 2023, Ariake)
3.  Japan-China Session at ChinaTrials 15 (Nov. 8, 2023, Shanghai)